Revista española de anestesiología y reanimación
-
Rev Esp Anestesiol Reanim · Feb 2010
Review[Sugammadex, a novel drug for neuromuscular blockade reversal].
Significant progress in the management of aminosteroid nondepolarizing neuromuscular blockers will follow the introduction of sugammadex (Org 25969). Safety and rapid recovery of muscle force will improve and the adverse effects of acetylcholinesterase inhibitors will be avoided. ⋯ Sugammadex was recently approved by the European Medicines Evaluation Agency and became available in Spain in 2009, leading to a series of changes related to patient safety and surgical conditions. We review the literature on sugammadex published to date.